title: Selective blockade of receptor-mediated cyclic GMP formation in N1E-115 neuroblastoma cells by an inhibitor of nitric oxide synthesis.
authors.affiliation: Department of Pharmacology, Mayo Clinic Jacksonville, FL 32224.
authors.forename: M
authors.initials: M
authors.lastname: McKinney
authors.forename: C
authors.initials: C
authors.lastname: Bolden
authors.forename: C
authors.initials: C
authors.lastname: Smith
authors.forename: A
authors.initials: A
authors.lastname: Johnson
authors.forename: E
authors.initials: E
authors.lastname: Richelson
mesh_terms: D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001920:Bradykinin / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D006152:Cyclic GMP / Q000096:biosynthesis*; D006632:Histamine / Q000494:pharmacology; D051379:Mice; D009447:Neuroblastoma / Q000378:metabolism*; D009496:Neurotensin / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D010716:Phosphatidylinositols / Q000378:metabolism; D011955:Receptors, Drug / Q000502:physiology*; D014407:Tumor Cells, Cultured / Q000378:metabolism; D019323:omega-N-Methylarginine
chemical_list: D010716:Phosphatidylinositols; D011955:Receptors, Drug; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D009496:Neurotensin; D006632:Histamine; D002217:Carbachol; D001120:Arginine; D006152:Cyclic GMP; D001920:Bradykinin